|
EP0921196A1
(en)
*
|
1997-12-02 |
1999-06-09 |
Roche Diagnostics GmbH |
Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
|
|
EP0922765B1
(en)
*
|
1997-12-02 |
2005-11-23 |
Roche Diagnostics GmbH |
Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
|
|
US20030228616A1
(en)
*
|
1999-10-29 |
2003-12-11 |
Stratagene |
DNA polymerase mutants with reverse transcriptase activity
|
|
US20050123940A1
(en)
*
|
1999-10-29 |
2005-06-09 |
Stratagene California |
Compositions and methods for synthesizing cDNA
|
|
US20040009486A1
(en)
*
|
1999-10-29 |
2004-01-15 |
Sorge Joseph A. |
Compositions and methods utilizing DNA polymerases
|
|
US7384739B2
(en)
*
|
2001-11-14 |
2008-06-10 |
Toyo Boseki Kabushiki Kaisha |
Compositions for enhancing DNA synthesis, DNA polymerase-related factors and utilization thereof
|
|
BRPI0408967B8
(pt)
|
2003-03-31 |
2021-07-27 |
Hoffmann La Roche |
kit e métodos para detecção de um ácido nucléico de vários membros do sorogrupo do vírus da encefalite japonesa em uma amostra biológica sob condições de hibridização rigorosas
|
|
US7927580B2
(en)
|
2004-03-16 |
2011-04-19 |
Nanirx, Inc. |
Tat-based immunomodulatory compositions and methods of their discovery and use
|
|
US8962293B2
(en)
|
2006-10-18 |
2015-02-24 |
Roche Molecular Systems, Inc. |
DNA polymerases and related methods
|
|
NZ595060A
(en)
|
2009-03-23 |
2013-05-31 |
Pin Pharma Inc |
Treatment of cancer with immunostimulatory hiv tat derivative polypeptides
|
|
JP5841136B2
(ja)
|
2010-06-18 |
2016-01-13 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
増大した３’末端ミスマッチ識別能を有するｄｎａポリメラーゼ
|
|
KR101622442B1
(ko)
|
2010-06-18 |
2016-05-19 |
에프. 호프만-라 로슈 아게 |
３’―미스매치 구별이 증가된 ｄｎａ 중합효소
|
|
WO2011157436A1
(en)
|
2010-06-18 |
2011-12-22 |
Roche Diagnostics Gmbh |
Dna polymerases with increased 3'-mismatch discrimination
|
|
CA2802000C
(en)
|
2010-06-18 |
2016-08-16 |
F. Hoffmann-La Roche Ag |
Dna polymerases with increased 3'-mismatch discrimination
|
|
CA2801997C
(en)
|
2010-06-18 |
2016-05-31 |
F. Hoffmann-La Roche Ag |
Dna polymerases with increased 3'-mismatch discrimination
|
|
JP5926246B2
(ja)
|
2010-06-18 |
2016-05-25 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
増大した３’末端ミスマッチ識別能を有するｄｎａポリメラーゼ
|
|
ES2536978T3
(es)
|
2010-06-18 |
2015-06-01 |
F. Hoffmann-La Roche Ag |
ADN polimerasas con discriminación incrementada de no correspondencias 3'
|
|
CA2802239C
(en)
|
2010-06-18 |
2016-08-23 |
F. Hoffmann-La Roche Ag |
Dna polymerases with increased 3'-mismatch discrimination
|
|
WO2012110061A1
(en)
|
2011-02-15 |
2012-08-23 |
Roche Diagnostics Gmbh |
Dna polymerases with increased 3'-mismatch discrimination
|
|
EP2697372B1
(en)
|
2011-04-11 |
2015-12-16 |
Roche Diagnostics GmbH |
Dna polymerases with improved activity
|
|
WO2013013822A1
(en)
|
2011-07-28 |
2013-01-31 |
Roche Diagnostics Gmbh |
Dna polymerases with improved activity
|
|
JP6144697B2
(ja)
|
2011-12-08 |
2017-06-07 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
改善された活性を有するｄｎａポリメラーゼ
|
|
WO2013083262A1
(en)
|
2011-12-08 |
2013-06-13 |
Roche Diagnostics Gmbh |
Dna polymerases with improved activity
|
|
JP6140182B2
(ja)
|
2011-12-08 |
2017-05-31 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
改善された活性を有するｄｎａポリメラーゼ
|
|
JP2016533352A
(ja)
|
2013-10-04 |
2016-10-27 |
ピーアイエヌ ファーマ インコーポレイテッド |
免疫刺激性ＨＩＶ Ｔａｔ誘導体ポリペプチドによる癌の治療
|
|
ES2969883T3
(es)
|
2018-03-21 |
2024-05-23 |
Hoffmann La Roche |
ADN polimerasas para la incorporación eficiente y eficaz de dNTP metilados
|
|
JP7504872B2
(ja)
|
2018-09-13 |
2024-06-24 |
エフ． ホフマン－ラ ロシュ アーゲー |
改善されたストランド置換能力を有する変異体ｄｎａポリメラーゼ
|
|
CN111733145A
(zh)
*
|
2020-07-01 |
2020-10-02 |
济南国科医工科技发展有限公司 |
重组酶的纯化方法
|